Skip to content
healthcare.dev

Ondansetron

NDC 71335-1731, Ondansetron, tablet, orally disintegrating, from Bryant Ranch Prepack.

Product NDC
71335-1731
Status
Listed
Labeler
Bryant Ranch Prepack
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090469
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1731 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONDANSETRON8 mg/1

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
71335-1731-0713351731003 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-0)
71335-1731-17133517310130 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-1)
71335-1731-27133517310210 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-2)
71335-1731-3713351731035 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-3)
71335-1731-4713351731044 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-4)
71335-1731-5713351731056 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-5)
71335-1731-67133517310614 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-6)
71335-1731-77133517310760 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-7)
71335-1731-87133517310812 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-8)
71335-1731-97133517310990 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (71335-1731-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2d1b8953-7ff5-4e91-ba97-3ba5c6ea8f71

Use it

Look up 71335-1731 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1731 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71335-1731. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.